Sionna Therapeutics (NASDAQ:SION) Shares Gap Up – Should You Buy?

Sionna Therapeutics, Inc. (NASDAQ:SION) gapped up before the market opened on Thursday . The stock had previously closed at $13.88, but opened at $14.18. Sionna Therapeutics shares last traded at $13.87, with a volume of 4,394 shares trading hands.

Analysts Set New Price Targets

SION has been the topic of several research analyst reports. TD Cowen initiated coverage on shares of Sionna Therapeutics in a research report on Tuesday, March 4th. They set a “buy” rating on the stock. Stifel Nicolaus initiated coverage on shares of Sionna Therapeutics in a research report on Tuesday, March 4th. They set a “buy” rating and a $32.00 price target on the stock. Finally, Guggenheim initiated coverage on shares of Sionna Therapeutics in a research report on Tuesday, March 4th. They set a “buy” rating and a $45.00 price target on the stock.

Sionna Therapeutics Stock Down 0.4 %

Sionna Therapeutics (NASDAQ:SION) last posted its quarterly earnings data on Thursday, March 20th. The company reported ($3.38) EPS for the quarter, missing the consensus estimate of ($2.68) by ($0.70).

About Sionna Therapeutics

We are a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (“CF”) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (“CFTR”) protein to deliver clinically meaningful benefit to CF patients.